Description The function of Head of HERA (ranked as a Director-General) is to be responsible for taking, in close coordination with the Directorate-General for Health and Food Safety, all measures necessary for the efficient functioning of the HERA consistent with the regulations in force and the authority delegated to them. The tasks will be the […]
Health Union: stronger EU response to public health emergencies
First Health Union package based on lessons learned from COVID-19 pandemic finalised EU to be better prepared and able to coordinate its response to health crises Clearer rules for joint procurement of medicines and medical devices Parliament approved new measures strengthening the EU’s capacity to prevent and control the outbreak of communicable diseases and tackle […]
Start of rolling review for adapted Spikevax COVID-19 vaccine
EMA has started a rolling review for a version of Spikevax adapted to provide better protection against specific variants of SARS-CoV-2, the virus that causes COVID-19. The review concerns a bivalent vaccine. This means it will target two strains of SARS-CoV-2, in this case the original strain and the Omicron variant of concern. The review […]
The UAL receives the verification of the curriculum of the Degree in Medicine
The positive report of verification of the degree by the DEVA is already a reality, which means that the first degree in Medicine will start next academic year 2022-2023 with 60 places. The rector of the UAL, Carmelo Rodríguez, assures that “this fulfils a historical demand that will have very positive repercussions for the University […]
Council adopts proposals aimed at securing the supply of medicines
Background With these proposals, the European Union intends to facilitate the implementation of the Protocol on Ireland/Northern Ireland on the ground, in line with the measures for Northern Ireland presented by the Commission on 13 October 2021. European Health Union: a stronger role for the European Medicines Agency About the proposals EU ambassadors today agreed on […]
European Health Union: a stronger role for the European Medicines Agency
As part of the on-going work to build a strong European Health Union, the Council has adopted the Regulation revising the mandate of the European Medicines Agency (EMA), taking an important step towards EMA’s reinforcement in crisis preparedness and management for medicinal products and medical devices. The new rules will allow the Agency to closely […]
EU-UK relations: Commission guarantees continued supply of medicines to Northern Ireland
The Commission has put forward proposals to ensure the continued long-term supply of medicines from Great Britain to Northern Ireland and to address outstanding supply concerns in Cyprus, Ireland and Malta. In the context of the Protocol on Ireland/Northern Ireland, this means that the same medicines will continue to be available in Northern Ireland at […]
Horizon Europe: Medical Technology and Devices: from Lab to Patient
Scope EU-funded early-stage Research on novel Medical Technologies and Devices is uncovering unique opportunities to benefits patients and support clinicians. Medical Technology and Devices businesses are facing long and capital-intensive product development cycles, complex regulatory procedures, slow market uptake requiring the support of key opinion leaders and intensive follow-up with early adopters. In addition to […]
H2020. Restricted Call to maximise impact of IMI2 JU objectives and scientific priorities
A major challenge in life sciences, in particular within the medicines development process, is the scale of the investment required, the stepwise approach, very long development timelines and the successful involvement of relevant stakeholders. Certain IMI2 JU topics, launched under IMI2 JU Calls for proposals that are now closed, anticipated in their corresponding work plans […]